The United Kingdom will not entry its share of vaccine doses from the COVAX program, says British High Commissioner to Canada Susan le Jeune d’Allegeershecque.
In an interview with Power & Politics, d’Allegeershecque informed host Vassy Kapelos that whereas the United Kingdom is one of the most important contributors to COVAX, it nonetheless would not see the necessity to entry its share of the vaccine doses.
“I don’t think there are any plans for us to access the doses, but we were in a slightly different position from Canada,” she stated.
The federal authorities has confronted criticism from charities and opposition events over its resolution to entry Canada’s share of doses from COVAX — a world vaccine-sharing initiative collectively co-ordinated by the World Health Organization, the Coalition for Epidemic Preparedness Innovations and Gavi, The Vaccine Alliance.
In a media assertion, Green Party chief Annamie Paul stated she was “embarrassed” by Ottawa’s resolution to entry vaccines from a program primarily designed to assist creating nations.
But the federal authorities defended its motion, saying COVAX has all the time been a part of the federal government’s efforts to acquire vaccines.
“COVAX has two streams. It has the self-financing stream for countries like Canada to purchase vaccines through and then it has the advance market commitment for donations to be made for countries who can’t purchase them,” stated International Development Minister Karina Gould in a Power & Politics interview.
The excessive commissioner additionally famous that Britain’s vaccine rollout is extra superior that Canada’s program.
“We’ve already vaccinated 15 and a half million people, which is something like 23 per cent of the population,” stated d’Allegeershecque. “So at the moment, we’re able to access the doses that we need without having to draw from the COVAX facility.”
Britain additionally has the capability to fabricate its personal vaccines domestically.
As it stands, Canada might obtain as much as 1.1 million doses of the AstraZeneca vaccine by way of the COVAX program by the tip of March.